XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Oct. 31, 2022 10,193,287      
Balance at Oct. 31, 2022 $ 102 $ 25,118 $ 16,649 $ 41,869
Stock-based compensation expense   687   687
Tax withholding related to vesting of restricted stock (in shares) (2,488)      
Tax withholding related to vesting of restricted stock   (12)   (12)
Consolidated net loss     (2,226) (2,226)
Issuance of restricted stock (in shares) 54,092      
Issuance of restricted stock $ 1     1
Issuance of restricted stock   (0)    
Balance (in shares) at Jul. 31, 2023 10,289,891      
Balance at Jul. 31, 2023 $ 103 25,878 14,423 40,404
Exercise of stock options (in shares) 45,000      
Exercise of stock options $ 0 85   85
Issuance of restricted stock   0    
Balance (in shares) at Apr. 30, 2023 10,290,377      
Balance at Apr. 30, 2023 $ 103 25,634 16,068 41,805
Stock-based compensation expense   246   246
Tax withholding related to vesting of restricted stock (in shares) (486)      
Tax withholding related to vesting of restricted stock   (2)   (2)
Consolidated net loss     (1,645) (1,645)
Balance (in shares) at Jul. 31, 2023 10,289,891      
Balance at Jul. 31, 2023 $ 103 25,878 14,423 40,404
Balance (in shares) at Oct. 31, 2023 10,343,223      
Balance at Oct. 31, 2023 $ 104 26,087 13,571 39,762
Stock-based compensation expense   744   744
Tax withholding related to vesting of restricted stock (in shares) (2,063)      
Tax withholding related to vesting of restricted stock   (9)   (9)
Consolidated net loss     (6,361) (6,361)
Issuance of restricted stock (in shares) 152,325      
Issuance of restricted stock $ 1      
Issuance of restricted stock   (1)    
Balance (in shares) at Jul. 31, 2024 10,493,485      
Balance at Jul. 31, 2024 $ 105 26,821 7,210 $ 34,136
Exercise of stock options (in shares)       0
Issuance of restricted stock   1    
Balance (in shares) at Apr. 30, 2024 10,495,548      
Balance at Apr. 30, 2024 $ 105 26,589 7,915 $ 34,609
Stock-based compensation expense   241   241
Tax withholding related to vesting of restricted stock (in shares) (2,063)      
Tax withholding related to vesting of restricted stock   (9)   (9)
Consolidated net loss     (705) (705)
Balance (in shares) at Jul. 31, 2024 10,493,485      
Balance at Jul. 31, 2024 $ 105 $ 26,821 $ 7,210 $ 34,136